For citations:
Demidova N.V., Galushko E.A., Glukhova S.I., Savushkina N.M., Satybaldyev A.M., Cherkasova M.V., Khoroshko N.V., Maglevanyi S.V., Gordeev A.V. ADALIMUMAB DISCONTINUATION IN PATIENTS WITH RHEUMATOID ARTHRITIS AFTER ACHIEVING SUSTAINED REMISSION. Rheumatology Science and Practice. 2018;56(3):316-320. (In Russ.) https://doi.org/10.14412/1995-4484-2018-316-320